Lobbying client
ROIVANT SCIENCES, INC.
Biotechnology Company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 5 of its records are shown together here.
Filings
30
Filed by
5
Reported in-house
—
Reported by firms
$1,130,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2017 to 2022
Filings
30 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination (No Activity) 1st Quarter 2022
|
THE CONAFAY GROUP, LLC | — reported |
|
4th Quarter - Report 4th Quarter 2021
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2021
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2021
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | — reported |
|
2nd Quarter - Report 2nd Quarter 2021
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
1st Quarter - Report 1st Quarter 2021
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | $50,000 reported |
|
Registration 1st Quarter 2021
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | — reported |
|
1st Quarter - Report 1st Quarter 2021
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
4th Quarter - Report 4th Quarter 2020
|
THE CONAFAY GROUP, LLC | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2020
|
THE CONAFAY GROUP, LLC | $20,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| TIBER CREEK GROUP | 9 | $540,000 |
| ACG ADVOCACY | 4 | $270,000 |
| THE CONAFAY GROUP, LLC | 8 | $140,000 |
| BGR GOVERNMENT AFFAIRS | 2 | $130,000 |
| BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | 2 | $50,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 16 |
| Pharmacy | PHA | 15 |
| Budget/Appropriations | BUD | 10 |
| Medical/Disease Research/Clinical Labs | MED | 8 |
| Telecommunications | TEC | 4 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| H.R. 2740 | 116th | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.